Outlook Therapeutics's market cap is currently $54.75M. The company's EPS TTM is $-7.938; its P/E ratio is ―; Outlook Therapeutics is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ -204.69K	$ -262.14K	$ -554.07K
Operating Income	$ -71.70M	$ -53.13M	$ -63.07M	$ -51.73M	$ -36.84M
EBITDA	$ -71.59M	$ -56.85M	$ -62.87M	$ -51.46M	$ -35.76M
Net Income	$ -75.37M	$ -58.98M	$ -66.05M	$ -53.16M	$ -35.24M
Balance Sheet
Cash & Short-Term Investments	$ 14.93T	$ 23.39M	$ 17.40M	$ 14.48M	$ 12.54M
Total Assets	$ 28.82T	$ 32.30M	$ 28.53M	$ 22.81M	$ 19.73M
Total Debt	$ 29.74M	$ 35.56M	$ 10.96M	$ 11.90M	$ 8.80M
Net Debt	$ 14.81M	$ 12.16M	$ -6.44M	$ -2.57M	$ -3.74M
Total Liabilities	$ 10.00T>	$ 46.74M	$ 19.79M	$ 18.20M	$ 16.91M
Stockholders' Equity	$ -73.08T	$ -14.44M	$ 8.74M	$ 4.61M	$ 2.83M
Cash Flow
Free Cash Flow	$ -68.79T	$ -42.97M	$ -56.67M	$ -54.25M	$ -31.79M
Operating Cash Flow	$ -68.79T	$ -42.97M	$ -56.67M	$ -54.25M	$ -31.79M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -900.00K
Financing Cash Flow	$ 60.33T	$ 48.97M	$ 59.59M	$ 56.19M	$ 37.21M

Currency in USD

Outlook Therapeutics Earnings and Revenue History

Income Statement >

Outlook Therapeutics Debt to Assets

Balance Sheet >

Outlook Therapeutics Cash Flow

Cash Flow >

Outlook Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing